Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.

Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.

Item
http://www.wikidata.org/entity/Q38149325
Interleukin-1β-induced Wnt5a enhances human corneal endothelial cell migration through regulation of Cdc42 and RhoA.A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER studyThe Soluble Guanylate Cyclase Stimulator IWP-953 Increases Conventional Outflow Facility in Mouse Eyes.Rho-Associated Kinase Inhibitors: Potential Future Treatments for Glaucoma.Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.Effect of Rho-kinase Inhibitor, Y27632, on Porcine Corneal Endothelial Cell Culture, Inflammation and Immune Regulation.TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor.Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.
P2860

Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.

Item
http://www.wikidata.org/entity/Q38149325
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.
@en
type
label
Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.
@en
prefLabel
Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.2013.840288
P407
P433
P478
P577
P698